Yogurt makers may now claim that their products can reduce the risk of Type 2 diabetes, according to new guidance from the Food and Drug Administration — with some caveats.

The facts

• The FDA decision allows yogurt companies to make a “qualified health claim” that regular yogurt consumption — at least two cups or three servings per week — may lower the risk of Type 2 diabetes.
• The claim must specify that there is limited scientific evidence supporting it. The FDA said there was some evidence linking yogurt intake and reduced risk of Type 2 diabetes “irrespective of fat or sugar content.” But this finding was based on observational studies that measure associations instead of a cause-and-effect relationship between a substance and disease, it added.
• In its guidance, the FDA noted opposing views including that the move could “encourage consumers to increase consumption of yogurts, including those that are high in added sugars.” Added sugars have been linked to a number of health problems, including diabetes. Acknowledging that concern, the FDA urged “careful consideration” of whether to use the claim “on products that could contribute significant amounts of added sugars to the diet.”

Background

The move follows a 2018 petition from representatives of Danone North America, which sells yogurt, beverages and baby formula among other food products. The petition cited 117 publications as evidence for the claim that yogurt consumption lessens the risk of Type 2 diabetes, the FDA said. At least six of the studies were at least partially funded by Danone or a related company, Reuters reported.

Danone North America welcomed the FDA announcement, saying in a statement that it hopes the move provides consumers with “simple, actionable information they can use to help lower their risk of developing Type 2 diabetes.”